U.S. Online Retail and Ecommerce Stock News

Why Nasdaq’s tokenized collateral move with Talos matters Nasdaq (NDAQ) is drawing fresh attention after announcing a partnership with Talos to integrate tokenized collateral workflows into its Calypso and Trade Surveillance platforms. This step directly targets institutional use of digital assets. See our latest analysis for Nasdaq. Despite headlines around tokenized collateral and Nasdaq’s presence at the Digital Asset Summit, the stock’s recent momentum has softened, with a 17.6% 90-day...

NewAmsterdam Pharma announced it would present multiple Phase 3 and outcomes-related data sets for its oral CETP inhibitor obicetrapib at the ACC.26 cardiology meeting in New Orleans, highlighting kidney function, safety and lipid-related cardiovascular risk metrics in high‑risk patients. An interesting angle for investors is that obicetrapib is being positioned as a low‑dose, oral option intended to complement or expand existing LDL‑lowering approaches, with European commercialization...

Assessing OneMain Holdings after recent share price pressure OneMain Holdings (OMF) has come under pressure recently, with the stock showing declines over the past week, month and past 3 months. This has prompted investors to reassess its valuation and recent financial profile. See our latest analysis for OneMain Holdings. The current share price of US$51.55 reflects recent weakness, with a 1 month share price return of a 6.31% decline and a year to date share price return of a 25.37%...

CrowdStrike recently unveiled a wave of AI- and agent-focused upgrades to its Falcon platform, expanded collaborations with IBM and Intel, and new offerings like Agentic MDR, Falcon Data Security, and Charlotte AI AgentWorks, while deepening ecosystem ties with partners including AWS, NVIDIA, EY, Nebius, and WWT. These moves position CrowdStrike at the center of “agentic SOC” and AI security workflows just as investors are increasingly worried that powerful new frontier AI models such as...

In March 2026, Dell Technologies (NYSE:DELL) introduced a reimagined commercial device portfolio aimed at enterprise users. The new Dell Pro notebooks and desktops feature AI ready hardware, Copilot+ experiences, modular design, and updated Intel and AMD chips. The launch shifts attention from Dell's earlier focus on AI servers and quantum security to client devices used by everyday workers and IT teams. Dell Technologies enters this product cycle with recent share price momentum, with...

If you are wondering whether Berkshire Hathaway's current share price offers value or mainly reflects reputation, the key is to look past the ticker and focus on what the underlying valuation signals are actually saying. The stock last closed at US$468.49, with returns of a 2.4% decline over 7 days, a 7.2% decline over 30 days, a 5.7% decline year to date, and a 12.0% decline over the past year, compared with gains of 51.0% over 3 years and 78.4% over 5 years. Recent coverage has focused on...

Earlier in March 2026, the European Medicines Agency’s CHMP issued a positive opinion to expand Rhythm Pharmaceuticals’ IMCIVREE (setmelanotide) label to treat obesity and control hunger in adults and children 4 years and older with acquired hypothalamic obesity due to hypothalamic injury or impairment, adding to the drug’s existing rare obesity indications. This European regulatory milestone, coming shortly after U.S. approval for acquired hypothalamic obesity, reinforces Rhythm’s focus on...

IHS Holding (NYSE:IHS) has drawn investor attention after recent share price moves, prompting a closer look at how its current valuation, business mix, and return profile line up for long term holders. See our latest analysis for IHS Holding. At a share price of $8.21, IHS Holding’s recent 30 day share price return of 2.62% and 90 day share price return of 9.91% sit alongside a 1 year total shareholder return of 57.28%. However, the 3 year total shareholder return is slightly negative, which...

Johnson & Johnson (NYSE:JNJ) has secured European approval for self or caregiver administration of Darzalex in multiple myeloma. The decision covers all ten approved indications for Darzalex and makes it the first oncology injectable in Europe to receive this type of authorization. The new label allows eligible patients to receive treatment at home instead of exclusively in hospital or clinic settings. For Johnson & Johnson, which has a large pharmaceutical segment focused on oncology and...

Earlier in March 2026, QUALCOMM held its annual shareholder meeting, increased its quarterly dividend to US$0.92 per share, authorized a US$20.00 billion buyback, and filed a US$3.13 billion common share shelf registration tied to an employee stock ownership plan, while shareholder proposals on special meetings and China risk reporting were not approved. These moves highlight QUALCOMM’s focus on capital returns and employee ownership at the same time some investors are pushing for greater...

AbbVie’s dermatology data and why it matters for the stock AbbVie (ABBV) just put a spotlight on its dermatology franchise at the 2026 American Academy of Dermatology meeting, sharing 24 abstracts across psoriasis, atopic dermatitis, vitiligo and alopecia areata, including late-stage and long-term safety data. See our latest analysis for AbbVie. Despite the strong dermatology update, recent partnerships, and governance debates, AbbVie’s share price has slipped in recent months. Its year to...

For investors considering whether Artivion at around US$35 per share still offers value or whether the recent run has already priced in the story, this article breaks down what the current market price might be implying. The stock has pulled back over the last week and month, with declines of 1.2% and 8.3%, respectively, while still sitting on a 43.6% return over 1 year and 176.1% over 3 years. Recent coverage has focused on Artivion's position in the medical equipment space and investor...

In March 2026, Colgate-Palmolive disclosed past shareholder proposals seeking an independent board chair and removal of DEI criteria from board candidate selection, while federal lawsuits challenged its mouth rinse packaging over alleged safety messaging for young children. These governance and legal pressures arrive just as Colgate-Palmolive promotes its new Optic White Pro Series Toothpaste, highlighting how product innovation now sits alongside intensified scrutiny of its board structure,...

Event context and why Gartner is on investors’ radar Gartner (IT) has come into focus after a sharp share price pullback, with the stock showing a 38.95% decline over the past 3 months and a 62.97% negative total return over the past year. See our latest analysis for Gartner. At the current share price of US$155.42, Gartner’s recent performance reflects fading momentum, with a 7 day share price return of a 4.41% decline and a 1 year total shareholder return of a 62.97% decline. If Gartner’s...

If you are wondering whether Bright Horizons Family Solutions at US$77.99 is priced attractively or asking too much for its prospects, the valuation picture is not as straightforward as the share price alone might suggest. The stock has seen a 4.7% gain over the past 30 days, but that sits against a 21.5% decline year to date and a 38.6% decline over the past year, which can shift how the market views both risk and potential reward. Recent coverage has focused on the company within the...

Recent analyst reports around Tyler Technologies (TYL) ahead of its upcoming fiscal first quarter 2026 earnings and June 9 investor day have drawn fresh attention to the stock, particularly given management’s long term 2030 financial targets and focus on SaaS. See our latest analysis for Tyler Technologies. Despite upbeat commentary around SaaS bookings and long term 2030 targets, Tyler Technologies’ share price has retreated, with a 90 day share price return of a 27.09% decline and a 1 year...

KeyBank, part of KeyCorp (NYSE:KEY), has partnered with Coastal Enterprises, Inc. to expand support for Maine entrepreneurs. The KeyBank Foundation awarded a US$200,000 grant in 2025 to CEI, a Maine based Community Development Financial Institution. The funding is intended to grow free and low cost business advising, and increase access to capital for entrepreneurs, especially in underserved and rural communities. For investors watching NYSE:KEY, this move highlights how a regional bank can...

In March 2026, Aflac Incorporated expanded its Group Life Term to 120 product by adding a hybrid long-term care rider that offers flexible, portable benefits usable for home- or facility-based care, including informal caregiving, though availability still varies by state. This innovation reflects Aflac’s push to address the “Silver Tsunami” and rising long-term care costs by letting policyholders tap life coverage during their lifetimes rather than only after death. Next, we’ll examine how...

Expro Group Holdings (XPRO) has been tapped to provide well testing services for Vulcan Energy’s Lionheart Project in Europe’s largest geothermal and lithium cluster, putting fresh attention on how this contract fits into the stock’s recent return profile. See our latest analysis for Expro Group Holdings. The Lionheart contract comes at a time when Expro’s 90 day share price return of 32.37% and 1 year total shareholder return of 80.18% have already drawn attention, following a relatively...

On March 20, 2026, PVH Corp.’s Board of Directors amended the company’s by-laws to lower the ownership threshold for shareholders to request a special meeting from a majority of outstanding common shares to 25%, adding new conditions and conforming governance provisions. This shift meaningfully increases the potential influence of significant shareholders over PVH’s corporate agenda, signaling a greater openness to investor input on key governance and strategic matters. Next, we’ll examine...

Event context and recent share performance Kite Realty Group Trust (KRG) has drawn investor attention after recent share price moves, with the stock down about 7% over the past month but roughly flat over the past 3 months. See our latest analysis for Kite Realty Group Trust. For context, the recent 7.3% 1 month share price decline comes after a relatively steady 1 year total shareholder return of 14.2% and 3 year total shareholder return of 33.4%. This suggests momentum has cooled in the...

What Webster Financial’s recent returns suggest for investors Webster Financial (WBS) has drawn attention after a recent one-month return decline of about 6% contrasted with a gain of roughly 6% over the past 3 months, prompting closer scrutiny of its fundamentals. For investors tracking banks, this mix of short term weakness and recent quarter strength raises questions about how the current share price of US$68.07 lines up with Webster Financial’s earnings profile, balance across business...

In recent years, Garrett Motion has reported stronger quarterly results alongside rising free cash flow margins and higher returns on invested capital, indicating more efficient operations. These improvements in cash generation and capital productivity suggest the company has been reshaping its business model to rely less on heavy investment needs. We’ll now examine how this improved free cash flow efficiency interacts with Garrett Motion’s existing investment narrative and future business...

For investors considering whether Coinbase Global at around US$161 per share is a bargain, fairly priced, or expensive, this article explains what the current stock price might indicate about value. The stock has experienced volatility recently, with a 19.7% decline over the last 7 days and a 31.9% decline year to date. Over a 3 year period the return stands at 153.3%, while the 1 year return reflects a 6.4% decline. Recent price movements have occurred against a backdrop of ongoing interest...